In the past years, we have drastically improved treatments for melanoma-skin cancer patients. Nevertheless, tumor recurrence still remains an highly lethal matter of our concern.

 

I’m pursing my PhD project in the melanoma genomics lab-group of Göran Jönssön, where we are specifically working with melanoma cells invulnerable towards current effective therapies.

Can we understand and trigger the mechanism which renders this particularly dangerous cancer cell type resistant?

” Hear more about it in my personal

PhD project video! “

 

 

Written by:
Adriana Sanna, ESR10

Lund University,
Sweden